LONDON, U.K., – Coulter Partners was delighted to partner with Zumutor Biologics, a leading Immuno-Oncology Company in the targeted NK cell therapeutics space, to secure the appointment of Ramon Valencia as Vice President, Corporate Development and Strategy. Ramon will help build on Zumutor’s key successes that include proprietary antibody discovery platforms and a compelling pipeline of

LONDON, U.K., – Coulter Partners was very pleased to partner with Biogazelle, specialists in liquid biopsies and non-coding RNA, to secure the appointment of Armin Winands as its new Chief Executive Officer. He follows co-founder Jan Hellemans, who will take on the role of CTO after 10 years as CEO. The appointment of Armin Winands is

SILICON VALLEY, CA – Coulter Partners was privileged to partner recently with Pivot Bio, an agriculture technology company based in Silicon Valley, to secure the appointments of Richard Broglie, Ph.D., as Chief Technology Officer and Ernie Sanders as Vice President of Product Development. These appointments further strengthen Pivot Bio’s leadership team to help drive the development

CAMBRIDGE, MA, January 3, 2018 – Coulter Partners was delighted to partner with Proclara Biosciences to help strengthen their leadership team with the appointment of David Michelson, M.D., as Chief Medical Officer. Proclara is a biotechnology company developing novel therapies for diseases caused by protein misfolding. Dr. Michelson joins Proclara from Merck Research Laboratories, where he served

LONDON, UK, January 8, 2018 – Coulter Partners was pleased to partner with Stevenage Bioscience Catalyst, to help secure the appointment of Dr Sally Ann Forsyth as Chief Executive Officer. Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, has announced that Dr Forsyth will join as CEO in March 2018. She